We then further investigated whether the combined analysis (e.g. Immunoscore (IS)) of both high and low CD3+ and CD8+ T cell densities in tumour regions (CT or IM) could improve the prediction of patient outcome, which has been successfully used to predict outcome of colon cancer and rectal cancer [5, 10, 12]. Here, CD8A is linked to neoplasm.